Conference Coverage

Some mutation testing can be useful at CLL diagnosis

Publish date: October 5, 2018

 

EXPERT ANALYSIS FROM MHM 2018

Pages

Recommended Reading

Isavuconazole resolved invasive fungal disease in patients on ibrutinib
B-Cell Lymphoma ICYMI
New chronic lymphocytic leukemia guidelines from the UK
B-Cell Lymphoma ICYMI
Caution urged over real-world bleeding risk with ibrutinib
B-Cell Lymphoma ICYMI
Combo treatment yields MRD-negative remissions in CLL
B-Cell Lymphoma ICYMI
RESONATE-2 update: First-line ibrutinib has sustained efficacy in older CLL patients
B-Cell Lymphoma ICYMI
Venetoclax label now includes MRD data
B-Cell Lymphoma ICYMI
FDA approves new hairy cell leukemia drug
B-Cell Lymphoma ICYMI
FDA approves new drug for CLL/SLL and follicular lymphoma
B-Cell Lymphoma ICYMI
Real-world clues for optimal sequencing of CLL novel agents
B-Cell Lymphoma ICYMI
Novel options for treating hairy cell leukemia
B-Cell Lymphoma ICYMI